Patents by Inventor Michael John CARR

Michael John CARR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240131327
    Abstract: The present invention provides devices and methods that can prevent or ameliorate bronchoconstriction by stimulating neural activity, in contrast to those techniques based on denervation, ablation or blocking of neural activity. Methods and devices according to the invention may act responsively or on demand, can preserve neuronal structure and function and will be associated with minimal collateral side-effects. In particular, the invention provides devices and methods in which signals are delivered to the vagus nerve in order to stimulate neural activity in the vagal nerve.
    Type: Application
    Filed: December 12, 2023
    Publication date: April 25, 2024
    Inventors: Michael John Carr, Kevin K. Kwong, Gerald E. Hunsberger
  • Patent number: 11878160
    Abstract: The present invention provides devices and methods that can prevent or ameliorate bronchoconstriction by stimulating neural activity, in contrast to those techniques based on denervation, ablation or blocking of neural activity. Methods and devices according to the invention may act responsively or on demand, can preserve neuronal structure and function and will be associated with minimal collateral side-effects. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve, for example the cervical vagus nerve or the pulmonary branch of the vagus nerve, in order to stimulate neural activity in the vagal nerve.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: January 23, 2024
    Assignee: Galvani Bioelectronics Limited
    Inventors: Michael John Carr, Kevin K. Kwong, Gerald E. Hunsberger
  • Publication number: 20230241396
    Abstract: The present invention provides an implantable neuromodulation system for delivering an electrical signal to a nerve to stimulate, inhibit or block conduction of action potentials in the nerve. The system comprises a neural interface device comprising first and second electrodes; a signal generator and a first closed-loop controller configured to generate a control signal based a property of the signal based on a measured voltage across the first and second electrodes, and cause the signal generator to adjust the electrical signal to modify the property of the signal.
    Type: Application
    Filed: June 18, 2021
    Publication date: August 3, 2023
    Applicant: GALVANI BIOELECTRONICS LIMITED
    Inventors: Michael John CARR, Rizwan BASHIRULLAH
  • Publication number: 20220054838
    Abstract: An implantable neurostimulation system comprises at least one neural interface device for stimulating and/or inhibiting neural activity in a nerve such as the cervical vagus nerve. The device comprises first and second electrodes and at least one signal generator configured to generate first and second electrical signals that stimulate and/or inhibit neural activity in the nerve via the first and second electrodes. The first electrical signal is configured to stimulate neural activity in the nerve to cause at least one pre-determined physiological response; and the second electrical signal is configured to inhibit neural activity in the nerve to at least partially suppress the least one pre-determined physiological response.
    Type: Application
    Filed: December 13, 2019
    Publication date: February 24, 2022
    Inventors: Michael John Carr, Rizwan Bashirullah, Kenichi Yoshida
  • Publication number: 20200009384
    Abstract: The invention provides devices and methods that can prevent or ameliorate bronchoconstriction. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve or the pulmonary branches of the vagus nerves. The signal is able to treat bronchoconstriction and prevent and/or ameliorate bronchoconstriction.
    Type: Application
    Filed: September 5, 2019
    Publication date: January 9, 2020
    Inventors: Brendan J. CANNING, Michael John CARR, Marian KOLLARIK
  • Patent number: 10441787
    Abstract: The invention provides devices and methods that can prevent or ameliorate bronchoconstriction. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve or the pulmonary branches of the vagus nerves. The signal is able to treat bronchoconstriction and prevent and/or ameliorate bronchoconstriction.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: October 15, 2019
    Assignees: GALVANI BIOELECTRONICS LIMITED, THE JOHNS HOPKINS UNIVERSITY
    Inventors: Brendan J. Canning, Michael John Carr, Marian Kollarik
  • Publication number: 20180236224
    Abstract: The present invention provides devices and methods that can prevent or ameliorate bronchoconstriction by stimulating neural activity, in contrast to those techniques based on denervation, ablation or blocking of neural activity. Methods and devices according to the invention may act responsively or on demand, can preserve neuronal structure and function and will be associated with minimal collateral side-effects. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve, for example the cervical vagus nerve or the pulmonary branch of the vagus nerve, in order to stimulate neural activity in the vagal nerve.
    Type: Application
    Filed: August 18, 2016
    Publication date: August 23, 2018
    Applicant: GALVANI BIOELECTRONICS LIMITED
    Inventors: Michael John CARR, Kevin K. KWONG, Gerald E. HUNSBERGER
  • Publication number: 20180043162
    Abstract: The invention provides devices and methods that can prevent or ameliorate bronchoconstriction. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve or the pulmonary branches of the vagus nerves. The signal is able to treat bronchoconstriction and prevent and/or ameliorate bronchoconstriction.
    Type: Application
    Filed: February 24, 2016
    Publication date: February 15, 2018
    Inventors: BRENDAN J. CANNING, Michael John CARR, Marian KOLLARIK